Search papers, labs, and topics across Lattice.
This study introduces a novel approach to multi-label activity prediction for antimicrobial peptides (AMPs) using a sequence-only pipeline that leverages 330 interpretable sequence descriptors combined with the TabPFN model. By doing so, it surpasses the performance of existing multimodal deep learning methods on the ESCAPE benchmark, achieving a mean average precision of 77.8% compared to the previous best of 72.1%. The findings highlight that simpler models can achieve competitive results without the extensive training and tuning typically required by more complex architectures, particularly excelling in predicting activities for remote homologues.
A straightforward sequence-only model outperforms complex multimodal approaches in predicting antimicrobial peptide activities, achieving a significant boost in precision.
Antimicrobial peptides (AMPs) often act against multiple pathogen classes, making multi-label activity prediction a more realistic screening target than binary antimicrobial classification. The ESCAPE benchmark formalizes this setting, but leading approaches typically rely on multimodal, structure-conditioned deep models that are costly to train and tune. We show that a simple, sequence-only pipeline can match and surpass these methods by combining 330 interpretable sequence descriptors with TabPFN, a tabular foundation model that performs in-context prediction in a single forward pass without gradient-based training or hyperparameter search. On ESCAPE (82,359 peptides; five labels), a label-powerset TabPFN model achieves mAP-5 = 77.8%, improving on the previously best reported 72.1%. A probabilistic classifier chain is the first method to match or exceed the best published average precision on each of the five labels simultaneously. The gains persist under the prior state-of-the-art single-fold training protocol, indicating they are not a training-set-size artefact, and are largest for remote homologues (+11.2 points below 30% sequence identity). Ablations further show that predicted structure is unnecessary at inference and that performance is not driven by any single descriptor family: ten global physicochemical scalars recover 91% of full-feature performance. Finally, explicitly modelling label dependence yields targeted benefits for scarce activities and supports ranking which activity to assay next from partial positive evidence.
